Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tumor Suppressor Protein p53 | 3 | 2010 | 380 | 0.600 |
Why?
|
Imidazoles | 3 | 2014 | 163 | 0.540 |
Why?
|
Piperazines | 3 | 2017 | 272 | 0.540 |
Why?
|
Interleukin-6 | 2 | 2006 | 255 | 0.490 |
Why?
|
Folic Acid | 1 | 2014 | 60 | 0.480 |
Why?
|
ras Proteins | 1 | 2014 | 128 | 0.460 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2010 | 74 | 0.430 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 645 | 0.380 |
Why?
|
Puromycin | 1 | 2009 | 10 | 0.350 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2009 | 3 | 0.350 |
Why?
|
Liver Neoplasms, Experimental | 2 | 2006 | 27 | 0.350 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 1073 | 0.340 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 99 | 0.340 |
Why?
|
Cytoskeleton | 1 | 2010 | 192 | 0.330 |
Why?
|
Reactive Oxygen Species | 3 | 2015 | 480 | 0.330 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2008 | 4 | 0.330 |
Why?
|
Lactams, Macrocyclic | 1 | 2008 | 14 | 0.330 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2009 | 113 | 0.330 |
Why?
|
Benzoquinones | 1 | 2008 | 27 | 0.330 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2008 | 46 | 0.320 |
Why?
|
Mitosis | 1 | 2008 | 151 | 0.310 |
Why?
|
Genetic Vectors | 1 | 2009 | 438 | 0.310 |
Why?
|
Myocytes, Cardiac | 3 | 2015 | 275 | 0.310 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2006 | 380 | 0.310 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 279 | 0.300 |
Why?
|
Protein Kinase Inhibitors | 3 | 2017 | 589 | 0.290 |
Why?
|
Cell Line, Tumor | 7 | 2016 | 2421 | 0.290 |
Why?
|
Cell Movement | 1 | 2010 | 756 | 0.290 |
Why?
|
Drug Implants | 1 | 2006 | 34 | 0.280 |
Why?
|
Receptors, Interleukin-6 | 1 | 2005 | 17 | 0.270 |
Why?
|
Toxicity Tests | 2 | 2015 | 13 | 0.260 |
Why?
|
Cell Proliferation | 2 | 2014 | 1571 | 0.250 |
Why?
|
Nuclear Proteins | 1 | 2009 | 694 | 0.250 |
Why?
|
Hepatocytes | 1 | 2005 | 127 | 0.250 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 554 | 0.240 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2015 | 101 | 0.230 |
Why?
|
Trans-Activators | 1 | 2005 | 429 | 0.210 |
Why?
|
Heart Diseases | 2 | 2015 | 290 | 0.210 |
Why?
|
Transcription Factors | 1 | 2009 | 1555 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2016 | 1196 | 0.180 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 1208 | 0.170 |
Why?
|
Genes, erbB-1 | 1 | 2017 | 16 | 0.160 |
Why?
|
Midazolam | 1 | 2017 | 48 | 0.160 |
Why?
|
Pyrazines | 1 | 2017 | 84 | 0.150 |
Why?
|
Pyrrolidines | 1 | 2017 | 58 | 0.150 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2016 | 4 | 0.140 |
Why?
|
Piperidines | 1 | 2017 | 181 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 123 | 0.130 |
Why?
|
Pyridazines | 1 | 2014 | 22 | 0.130 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 55 | 0.130 |
Why?
|
Signal Transduction | 4 | 2016 | 3233 | 0.130 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2014 | 4 | 0.120 |
Why?
|
B7-H1 Antigen | 1 | 2016 | 250 | 0.120 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 1 | 2013 | 14 | 0.120 |
Why?
|
Activins | 1 | 2013 | 26 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 2351 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 153 | 0.110 |
Why?
|
Cell Survival | 3 | 2015 | 966 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 458 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2016 | 556 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2013 | 551 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 286 | 0.100 |
Why?
|
G2 Phase | 2 | 2008 | 34 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 302 | 0.100 |
Why?
|
Antigens, CD | 1 | 2013 | 457 | 0.100 |
Why?
|
HCT116 Cells | 2 | 2008 | 150 | 0.100 |
Why?
|
Genomics | 1 | 2016 | 710 | 0.090 |
Why?
|
Stress Fibers | 1 | 2010 | 23 | 0.090 |
Why?
|
Pseudopodia | 1 | 2010 | 35 | 0.090 |
Why?
|
Mutation | 3 | 2017 | 3952 | 0.090 |
Why?
|
Focal Adhesions | 1 | 2010 | 69 | 0.090 |
Why?
|
Promyelocytic Leukemia Protein | 1 | 2009 | 8 | 0.090 |
Why?
|
SUMO-1 Protein | 1 | 2009 | 16 | 0.090 |
Why?
|
Polyploidy | 1 | 2008 | 17 | 0.090 |
Why?
|
Rats | 2 | 2006 | 3984 | 0.080 |
Why?
|
Cell Line | 2 | 2014 | 2466 | 0.080 |
Why?
|
Humans | 12 | 2017 | 86281 | 0.080 |
Why?
|
HT29 Cells | 1 | 2008 | 49 | 0.080 |
Why?
|
Cell Differentiation | 1 | 2014 | 1456 | 0.080 |
Why?
|
DNA Replication | 1 | 2008 | 164 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 1958 | 0.080 |
Why?
|
Protein Folding | 1 | 2009 | 280 | 0.080 |
Why?
|
Actins | 1 | 2010 | 448 | 0.070 |
Why?
|
Cell Division | 1 | 2008 | 696 | 0.070 |
Why?
|
Hexuronic Acids | 1 | 2006 | 10 | 0.070 |
Why?
|
Glucuronic Acid | 1 | 2006 | 11 | 0.070 |
Why?
|
Animals | 4 | 2014 | 26518 | 0.070 |
Why?
|
Alginates | 1 | 2006 | 15 | 0.070 |
Why?
|
Cricetulus | 1 | 2006 | 126 | 0.070 |
Why?
|
CHO Cells | 1 | 2006 | 187 | 0.070 |
Why?
|
Rats, Inbred ACI | 1 | 2005 | 25 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 68 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2005 | 87 | 0.070 |
Why?
|
Cricetinae | 1 | 2006 | 560 | 0.060 |
Why?
|
STAT3 Transcription Factor | 1 | 2005 | 78 | 0.060 |
Why?
|
Drug Compounding | 1 | 2006 | 77 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 376 | 0.060 |
Why?
|
Random Allocation | 1 | 2005 | 332 | 0.060 |
Why?
|
Probability | 1 | 2005 | 355 | 0.060 |
Why?
|
Transfection | 1 | 2006 | 895 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 877 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 1708 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2013 | 692 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2015 | 446 | 0.050 |
Why?
|
Disease Progression | 1 | 2006 | 1531 | 0.050 |
Why?
|
Base Sequence | 1 | 2005 | 2329 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 1987 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 3029 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2006 | 731 | 0.050 |
Why?
|
Mice | 1 | 2014 | 11313 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 589 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2015 | 2810 | 0.040 |
Why?
|
Male | 4 | 2017 | 40860 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2005 | 2227 | 0.040 |
Why?
|
Risk Assessment | 2 | 2015 | 2253 | 0.040 |
Why?
|
Receptor, ErbB-3 | 1 | 2016 | 18 | 0.040 |
Why?
|
Mutation Rate | 1 | 2016 | 48 | 0.030 |
Why?
|
Time Factors | 2 | 2015 | 5198 | 0.030 |
Why?
|
Troponin I | 1 | 2015 | 26 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 262 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2016 | 369 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 182 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2017 | 1203 | 0.030 |
Why?
|
Troponin | 1 | 2014 | 24 | 0.030 |
Why?
|
Mitochondria, Heart | 1 | 2014 | 50 | 0.030 |
Why?
|
Molecular Structure | 1 | 2015 | 287 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 547 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 408 | 0.030 |
Why?
|
Smad1 Protein | 1 | 2013 | 3 | 0.030 |
Why?
|
Activin Receptors, Type II | 1 | 2013 | 9 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2015 | 196 | 0.030 |
Why?
|
Endoglin | 1 | 2013 | 20 | 0.030 |
Why?
|
Cell Death | 1 | 2014 | 256 | 0.030 |
Why?
|
ERG1 Potassium Channel | 1 | 2013 | 14 | 0.030 |
Why?
|
Caspase 7 | 1 | 2013 | 15 | 0.030 |
Why?
|
Neoplasms | 1 | 2008 | 2889 | 0.030 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2013 | 26 | 0.030 |
Why?
|
Erlotinib Hydrochloride | 1 | 2013 | 90 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2013 | 31 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 86 | 0.030 |
Why?
|
Caspase 3 | 1 | 2013 | 159 | 0.030 |
Why?
|
Actin Cytoskeleton | 1 | 2014 | 190 | 0.030 |
Why?
|
Computational Biology | 1 | 2016 | 528 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 455 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 272 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 2013 | 396 | 0.030 |
Why?
|
Pyrazoles | 1 | 2013 | 153 | 0.030 |
Why?
|
Heart Rate | 1 | 2014 | 492 | 0.030 |
Why?
|
Pyrroles | 1 | 2013 | 184 | 0.030 |
Why?
|
Quinazolines | 1 | 2013 | 220 | 0.030 |
Why?
|
Lipids | 1 | 2013 | 269 | 0.030 |
Why?
|
Ion Channels | 1 | 2013 | 245 | 0.030 |
Why?
|
Indoles | 1 | 2013 | 318 | 0.030 |
Why?
|
Cholesterol | 1 | 2013 | 356 | 0.020 |
Why?
|
Pyridines | 1 | 2013 | 309 | 0.020 |
Why?
|
Pyrimidines | 1 | 2013 | 370 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 1381 | 0.020 |
Why?
|
Protein Binding | 1 | 2013 | 1454 | 0.020 |
Why?
|
RNA | 1 | 2013 | 560 | 0.020 |
Why?
|
Cyclin B | 1 | 2008 | 17 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2008 | 17 | 0.020 |
Why?
|
Cyclin A | 1 | 2008 | 28 | 0.020 |
Why?
|
Models, Biological | 1 | 2016 | 1748 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 43 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 2008 | 45 | 0.020 |
Why?
|
G1 Phase | 1 | 2008 | 63 | 0.020 |
Why?
|
Biomarkers | 1 | 2015 | 1709 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2015 | 2699 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 6481 | 0.020 |
Why?
|
DNA Damage | 1 | 2008 | 362 | 0.020 |
Why?
|
Female | 2 | 2017 | 44405 | 0.010 |
Why?
|
DNA | 1 | 2008 | 1293 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 1678 | 0.010 |
Why?
|
Aged | 1 | 2017 | 18353 | 0.010 |
Why?
|
Middle Aged | 1 | 2017 | 24957 | 0.010 |
Why?
|
Adult | 1 | 2017 | 25577 | 0.010 |
Why?
|